TransCode Therapeutics, Inc. (RNAZ)
NASDAQ: RNAZ · Real-Time Price · USD
0.385
+0.005 (1.18%)
At close: Nov 22, 2024, 4:00 PM
0.388
+0.003 (0.81%)
After-hours: Nov 22, 2024, 6:11 PM EST
TransCode Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Cash & Equivalents | 1.88 | 2.77 | 4.97 | 20.83 | 0.83 | 0.2 | Upgrade
|
| Short-Term Investments | - | - | 0.01 | 0.01 | 0 | - | Upgrade
|
| Cash & Short-Term Investments | 1.88 | 2.77 | 4.98 | 20.84 | 0.83 | 0.2 | Upgrade
|
| Cash Growth | -74.83% | -44.40% | -76.11% | 2406.60% | 306.52% | -3.99% | Upgrade
|
| Prepaid Expenses | 1.72 | 0.55 | 1.38 | 1.46 | - | - | Upgrade
|
| Other Current Assets | 0.01 | 1.14 | 1.02 | 0.44 | - | - | Upgrade
|
| Total Current Assets | 3.61 | 4.46 | 7.38 | 22.73 | 0.83 | 0.2 | Upgrade
|
| Property, Plant & Equipment | 0.21 | 0.6 | 0.21 | 0.21 | - | - | Upgrade
|
| Long-Term Deferred Charges | - | - | - | - | 0.22 | - | Upgrade
|
| Other Long-Term Assets | 0.11 | 0.11 | - | - | - | - | Upgrade
|
| Total Assets | 3.94 | 5.17 | 7.59 | 22.94 | 1.06 | 0.2 | Upgrade
|
| Accrued Expenses | - | 3.05 | 4.35 | 2.5 | 0.4 | 0.06 | Upgrade
|
| Current Portion of Leases | 0.15 | 0.41 | - | - | - | - | Upgrade
|
| Current Unearned Revenue | - | 0.03 | - | 0.03 | - | - | Upgrade
|
| Total Current Liabilities | 2.28 | 3.49 | 4.35 | 2.53 | 0.4 | 0.06 | Upgrade
|
| Long-Term Debt | - | - | - | - | 2.09 | 0.93 | Upgrade
|
| Long-Term Leases | - | 0.04 | - | - | - | - | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | 1.97 | 0.32 | Upgrade
|
| Total Liabilities | 2.28 | 3.53 | 4.35 | 2.53 | 4.46 | 1.31 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 58.91 | 48.06 | 31.11 | 30.71 | 0.07 | 0.02 | Upgrade
|
| Retained Earnings | -57.26 | -46.42 | -27.87 | -10.31 | -3.46 | -1.12 | Upgrade
|
| Comprehensive Income & Other | - | - | - | - | -0.01 | -0.01 | Upgrade
|
| Shareholders' Equity | 1.65 | 1.64 | 3.24 | 20.4 | -3.41 | -1.11 | Upgrade
|
| Total Liabilities & Equity | 3.94 | 5.17 | 7.59 | 22.94 | 1.06 | 0.2 | Upgrade
|
| Total Debt | 0.15 | 0.45 | - | - | 2.09 | 0.93 | Upgrade
|
| Net Cash (Debt) | 1.72 | 2.32 | 4.98 | 20.84 | -1.26 | -0.72 | Upgrade
|
| Net Cash Growth | -74.87% | -53.45% | -76.11% | - | - | - | Upgrade
|
| Net Cash Per Share | 0.25 | 12.94 | 306.86 | 1978.28 | - | - | Upgrade
|
| Filing Date Shares Outstanding | 17.27 | 5.81 | 0.02 | 0.02 | - | - | Upgrade
|
| Total Common Shares Outstanding | 17.27 | 0.63 | 0.02 | 0.02 | - | - | Upgrade
|
| Working Capital | 1.33 | 0.96 | 3.03 | 20.2 | 0.43 | 0.14 | Upgrade
|
| Book Value Per Share | 0.10 | 2.62 | 199.77 | 1264.92 | - | - | Upgrade
|
| Tangible Book Value | 1.65 | 1.64 | 3.24 | 20.4 | -3.41 | -1.11 | Upgrade
|
| Tangible Book Value Per Share | 0.10 | 2.62 | 199.77 | 1264.92 | - | - | Upgrade
|
| Machinery | - | 0.38 | 0.35 | 0.25 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.